CTVA earnings analysis
What we found in CTVA's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Corteva, Inc. reported strong Q1 2026 earnings with revenue of $4.90 billion, an 11% increase from the previous period, and EPS of $1.50, beating estimates. The Seed segment outperformed with 12% growth, while Crop Protection grew 10%, further supported by favorable currency impacts. A substantial $370 million was returned to shareholders during the quarter, highlighting Corteva's robust cash flow management despite a significant restructuring charge.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Growth Beat
- Reported revenue was $4,905 million, up 11% year-over-year, exceeding the forecast of $4,640 million.
- Strong EPS Performance
- EPS for Q1 2026 stood at $1.50, outperforming estimates of $1.18 and reflecting a solid growth trend.
- Seed Segment Leads Growth
- Seed segment revenue reached $3,023 million, up 12% versus $2,707 million a year ago, driven by significant volume increases.
- Solid Operating EBITDA
- Operating EBITDA increased to $1,438 million for Q1 2026, up from $1,189 million in the same period last year.
- Cash Returns to Shareholders
- Corteva returned approximately $370 million to shareholders, continuing its commitment to capital return.
- Effective Tax Rate Improvement
- Effective tax rate for Q1 2026 was 15.5%, aided by net tax benefits of $35 million from intellectual property realignment.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Increased Debt Levels
- Total debt rose to $3,356 million from $2,580 million at the end of 2025, reflecting a need to fund working capital.
- Restructuring Costs
- Incurring pre-tax restructuring charges of $92 million in Q1 2026, significantly higher than $22 million in Q1 2025.
- Operating Cash Flow Decline
- Operating cash flow was $(2,885) million in Q1 2026, worsening from $(2,101) million in Q1 2025, driven by increased compensation payments.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $1.5
- Gross margin
- 48%
- Segment
- Seed: $3,023 million, Crop Protection: $1,882 million
What they said about what is next.
The company reaffirmed its full-year 2026 guidance with operating EBITDA expected between $4.0 billion to $4.2 billion and EPS anticipated in the range of $3.45 to $3.70.
The filing reads better than the one before it.
What came before.
- 10-K · February 12, 2026
- Corteva describes itself as a global leader in seed and crop protection with a broad product pipeline and presence in approximately 110 countries, and announced on October 1, 2025 its intent to separate Seed and Crop…
- 10-K · February 14, 2025
- Corteva positions itself as a global leader in Seed and Crop Protection with a broad innovation pipeline and sales footprint in approximately 110 countries, supported by about 22,000 employees and a large patent estate…
- 10-Q · May 2, 2024
- Corteva reported Q1 net sales of $4,492 million, down $392 million (-8.0%) versus Q1 2023, with GAAP diluted EPS of $0.60. Seed sales grew to $2,751 million while Crop Protection fell to $1,741 million; gross margin…
- 10-K · February 9, 2023
- Corteva positions itself as a global leader in seeds and crop protection with “one of the broadest and most productive new product pipelines in the agriculture industry,” serving farmers in approximately 140 countries.…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CTVA makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever